Previously, SRA1 has been suggested to predict hepatocellular carcinoma(HCC) development due to its significant association with tumor size and serumglucose level, indicating that SRA1 may be a novel biomarker of HCC [16]. This evidence concerns the gene SRA1 and neoplasm.